首页> 外文期刊>Journal of Optometry >Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study
【24h】

Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study

机译:滴眼剂对瞳孔扩张的功效:随机对照研究

获取原文
       

摘要

Purpose Pupillary dilatation with three types of eye drops is used regularly in the clinic; however, a mixture of these drops in a single bottle may be more beneficial in reducing workloads and resources. This study compared the efficacy in pupillary dilatation between two protocols of dilating drop instillation. Methods This prospective, randomized, comparative study included 30 eligible Thai patients. The patients randomly received preoperative pupillary dilatations by either the conventional protocol (1% tropicamide (T), 10% phenylephrine (P) and 0.1% diclofenac (D) in three separate bottles) or the fixed combination (TPD) protocol which had the three types of eye drops mixed in a single bottle in a ratio of 4:3:3. The chi-square test and independent t -test were used to analyze the data. Results The conventional protocol group and TPD protocol group each had 15 patients. Sixty minutes after the initial instillation, all patients in the TPD protocol and 13 patients (86.7%) in conventional protocol achieved at least 6?mm in the shortest diameter. The mydriatic rate between protocols showed no difference. In patients who received the TPD protocol, the systemic effects on the mean arterial blood pressure and pulse rate decreased over time. Conclusion The mixture of tropicamide, phenylephrine and diclofenac had a comparable efficacy for a pupillary dilatation to the conventional dilating drops in separate bottles. The systemic complications on blood pressure and arterial pulse of the TPD mixture were less than the conventional protocol. Trial registration TCTR20130325001.
机译:目的临床上经常使用瞳孔扩张术和三种滴眼剂。但是,将这些液滴混合在一个瓶子中可能会更有利于减少工作量和资源。这项研究比较了两种滴滴法在瞳孔扩张中的功效。方法这项前瞻性,随机,比较研究纳入了30名合格的泰国患者。患者通过常规方案(在三个单独的瓶子中分别使用1%托吡卡因(T),10%苯肾上腺素(P)和0.1%双氯芬酸(D))或采用固定剂量组合(TPD)的方案随机接受术前瞳孔扩张术各种类型的眼药水以4:3:3的比例混合在一个瓶子中。卡方检验和独立t检验用于分析数据。结果常规方案组和TPD方案组各有15例患者。初次滴注后60分钟,所有采用TPD方案的患者和13例常规方案的患者的最短直径至少达到6毫米。协议之间的散瞳率没有差异。在接受TPD方案的患者中,对平均动脉血压和脉搏率的全身性影响会随着时间而降低。结论托尼酰胺,去氧肾上腺素和双氯芬酸的混合物在瞳孔扩张方面的功效与在单独瓶中的传统扩张滴剂相当。 TPD混合物在血压和动脉搏动方面的全身并发症比常规方案少。试用注册TCTR20130325001。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号